Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Unihealth Hospitals's interest expense for the
six
months ended in Mar. 2026 was ₹ -20 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-20 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Unihealth Hospitals Interest Expense Historical Data
* Premium members only.
The historical data trend for Unihealth Hospitals's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unihealth Hospitals (NSE:UNIHEALTH) has a Interest Expense of ₹-20 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Unihealth Hospitals and its competitors.
Is Unihealth Hospitals' Interest Expense too high?
Unihealth Hospitals' current Interest Expense is ₹-20 Mil. Overall, Unihealth Hospitals has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unihealth Hospitals' Interest Expense compare to HCA and THC?
Unihealth Hospitals' Interest Expense of ₹-20 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Unihealth Hospitals and its competitors. Unihealth Hospitals's current Interest Expense is ₹-20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unihealth Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Unihealth Hospitals (NSE:UNIHEALTH) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹385.66, compared to a current price of ₹751.10 — trading 94.8% above its estimated fair value. The current Interest Expense is ₹-20 Mil. Unihealth Hospitals' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Unihealth Hospitals (NSE:UNIHEALTH), the current Interest Expense is ₹-20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unihealth Hospitals (NSE:UNIHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Unihealth Hospitals stock appears to be overvalued.
The current stock price of ₹751.10 is trading 94.8% above its estimated GF Value™ of ₹385.66.
GuruFocus considers Unihealth Hospitals to be Significantly Overvalued.
Key valuation signals for NSE:UNIHEALTH:
Interest Expense: ₹-20 Mil
GF Value™: ₹385.66 vs. price of ₹751.10 (94.8% above fair value)
No single metric tells the full story. See the NSE:UNIHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unihealth Hospitals Ltd is a healthcare service provider based out of India and has an operational presence in multiple countries across the African continent. The company is predominantly engaged in the business of medical tour operators, health consultancy services, and also trades in medical equipment. The company has only one reportable Business Segment, which is Healthcare Services and Trading in its related products. Geographically, the company derives revenue from India, Uganda, Tanzania, Nigeria, the UAE, and Mauritius.
59GF Score
Get the complete analysis for NSE:UNIHEALTH
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIHEALTH has been successfully added to your 
